In agreement with these findings, studies performed in J20 mice, an in vivo model of AD in which Aβ senile plaques develop spontaneously, demonstrated decreased Aβ plaques in hippocampus of AD animals upon treatment with P2X7 receptor antagonist BBG. The gene discussed is P2RX7; the disease is Alzheimer disease.